Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,089,177
-$245,290 QoQ
Shares Held
8,621
-10.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#1,035
of 2,266 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026One Wealth Advisors, LLC holds $6,025,804 across 9 Drug Manufacturers - General names. GILD ranks #1 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
This page
|
8,621 | $1,089,177 | |
| 2 | JNJ |
Johnson & Johnson
|
4,046 | $1,027,562 | |
| 3 | NVS |
Novartis AG
|
5,053 | $791,906 | |
| 4 | LLY |
ELI LILLY & Co
|
654 | $784,427 | |
| 5 | AZN |
Astrazeneca PLC
|
3,637 | $689,647 | |
| 6 | ABBV |
AbbVie Inc.
|
2,596 | $653,257 | |
| 7 | BIIB |
Biogen Inc.
|
1,599 | $345,479 | |
| 8 | PFE |
Pfizer Inc
|
13,732 | $330,666 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,089,177 | 8,621 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,334,467 | 9,575 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,374,319 | 11,197 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $993,228 | 8,948 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,015,901 | 9,163 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $761,827 | 6,799 | Shares | Sole | 2025-05-06 | |
| 2023-12-31 | $241,166 | 2,977 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $261,615 | 3,491 | Shares | Sole | 2023-11-01 | |
| No filing history on record for this holder in this stock. | ||||||